{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:54:14Z","timestamp":1790891654645,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["-2015-05112"],"award-info":[{"award-number":["-2015-05112"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jbc.2021.101073","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:18:06Z","timestamp":1628723886000},"page":"101073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The aminoglycoside G418 hinders de novo prion infection in cultured cells"],"prefix":"10.1016","volume":"297","author":[{"given":"Hamza","family":"Arshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeel","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Mehrabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.C.","family":"Bourkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid A.M.","family":"Al-Azzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-0919","authenticated-orcid":false,"given":"Gerold","family":"Schmitt-Ulms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-2925","authenticated-orcid":false,"given":"Joel C.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.101073_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006833","article-title":"Prions","volume":"3","author":"Colby","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jbc.2021.101073_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41576-018-0011-4","article-title":"Prions, prionoids and protein misfolding disorders","volume":"19","author":"Scheckel","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2021.101073_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.101073_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","article-title":"A\u00a0cellular gene encodes scrapie PrP 27-30 protein","volume":"40","author":"Oesch","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101073_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","article-title":"Scrapie prion protein contains a phosphatidylinositol glycolipid","volume":"51","author":"Stahl","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101073_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/382180a0","article-title":"NMR structure of the mouse prion protein domain PrP(121-231)","volume":"382","author":"Riek","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101073_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-017-1790-y","article-title":"The function of the cellular prion protein in health and disease","volume":"135","author":"Watts","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2021.101073_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416679074","article-title":"NCAM1 polysialylation: The prion protein's elusive reason for being?","volume":"8","author":"Mehrabian","year":"2016","journal-title":"ASN Neuro"},{"key":"10.1016\/j.jbc.2021.101073_bib9","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.90.23.10962","article-title":"Conversion of \u03b1-helices into \u03b2-sheets features in the formation of the scrapie prion proteins","volume":"90","author":"Pan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib10","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1074\/jbc.R114.550707","article-title":"Mouse models for studying the formation and propagation of prions","volume":"289","author":"Watts","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-017-1670-5","article-title":"Prion disease: Experimental models and reality","volume":"133","author":"Brandner","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2021.101073_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/v5010374","article-title":"Cellular aspects of prion replication in\u00a0vitro","volume":"5","author":"Grassmann","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2021.101073_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1099\/0022-1317-68-5-1391","article-title":"Characterization of scrapie infection in mouse neuroblastoma cells","volume":"68","author":"Race","year":"1987","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/jvi.62.5.1558-1564.1988","article-title":"Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins","volume":"62","author":"Butler","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib15","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1128\/jvi.71.11.8821-8831.1997","article-title":"A\u00a0hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis","volume":"71","author":"Schatzl","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib16","doi-asserted-by":"crossref","first-page":"20908","DOI":"10.1073\/pnas.0710054104","article-title":"Prion strain discrimination in cell culture: The cell panel assay","volume":"104","author":"Mahal","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib17","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/20.13.3351","article-title":"Scrapie strains maintain biological phenotypes on propagation in a cell line in culture","volume":"20","author":"Birkett","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2021.101073_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/381166","article-title":"Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents","volume":"189","author":"Vorberg","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jbc.2021.101073_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003755","article-title":"Infectious prions accumulate to high levels in non proliferative C2C12 myotubes","volume":"9","author":"Herbst","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jnc.14956","article-title":"Cellular models for discovering prion disease therapeutics: Progress and challenges","volume":"153","author":"Krance","year":"2020","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jbc.2021.101073_bib21","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/JVI.02145-09","article-title":"Discovery of 2-aminothiazoles as potent antiprion compounds","volume":"84","author":"Ghaemmaghami","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib22","doi-asserted-by":"crossref","first-page":"E4160","DOI":"10.1073\/pnas.1317164110","article-title":"Drug resistance confounding prion therapeutics","volume":"110","author":"Berry","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.113.205799","article-title":"Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice","volume":"347","author":"Lu","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2021.101073_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.115.224659","article-title":"Different 2-aminothiazole therapeutics produce distinct patterns of scrapie prion neuropathology in mouse brains","volume":"355","author":"Giles","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2021.101073_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.116.235556","article-title":"Optimization of aryl amides that extend survival in prion-infected mice","volume":"358","author":"Giles","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2021.101073_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115939","article-title":"Generation of a persistently infected MDBK cell line with natural bovine spongiform encephalopathy (BSE)","volume":"10","author":"Tark","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.101073_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.80.2.596-604.2006","article-title":"Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease","volume":"80","author":"Raymond","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib28","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1083\/jcb.110.6.2117","article-title":"Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells","volume":"110","author":"Taraboulos","year":"1990","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbc.2021.101073_bib29","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1128\/JVI.00633-10","article-title":"Cell-based quantification of chronic wasting disease prions","volume":"84","author":"Bian","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib30","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.061337998","article-title":"Ex\u00a0vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein","volume":"98","author":"Vilette","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1099\/vir.0.83344-0","article-title":"A\u00a0cell line infectible by prion strains from different species","volume":"89","author":"Courageot","year":"2008","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib32","doi-asserted-by":"crossref","first-page":"18702","DOI":"10.1074\/jbc.M701309200","article-title":"Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins","volume":"282","author":"Maas","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01686-16","article-title":"PrP knockout cells expressing transmembrane PrP resist prion infection","volume":"91","author":"Marshall","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib34","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1074\/jbc.RA118.007135","article-title":"Engineering a murine cell line for the stable propagation of hamster prions","volume":"294","author":"Bourkas","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib35","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1038\/s41598-019-47629-z","article-title":"Gene-edited murine cell lines for propagation of chronic wasting disease prions","volume":"9","author":"Walia","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2021.101073_bib36","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000814","article-title":"Prion infection, transmission, and cytopathology modeled in a low-biohazard human cell line","volume":"3","author":"Avar","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.jbc.2021.101073_bib37","first-page":"327","article-title":"Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter","volume":"1","author":"Southern","year":"1982","journal-title":"J.\u00a0Mol. Appl. Genet."},{"key":"10.1016\/j.jbc.2021.101073_bib38","doi-asserted-by":"crossref","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","article-title":"Aminoglycoside interactions and impacts on the eukaryotic ribosome","volume":"114","author":"Prokhorova","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/287869a0","article-title":"Expression of a transposable antibiotic resistance element in Saccharomyces","volume":"287","author":"Jimenez","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101073_bib40","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1523\/JNEUROSCI.13-03-01280.1993","article-title":"Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice","volume":"13","author":"Suri","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.101073_bib41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1523\/JNEUROSCI.17-04-01217.1997","article-title":"Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation","volume":"17","author":"Qi","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.101073_bib42","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1128\/JVI.00181-12","article-title":"The extended cell panel assay characterizes the relationship of prion strains RML, 79A, and 139A and reveals conversion of 139A to 79A-like prions in cell culture","volume":"86","author":"Oelschlegel","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JVI.74.1.320-325.2000","article-title":"Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein","volume":"74","author":"Nishida","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib44","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib45","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1128\/JVI.74.9.4377-4386.2000","article-title":"Cultured cell sublines highly susceptible to prion infection","volume":"74","author":"Bosque","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-5793(97)00452-3","article-title":"Addition of G418 and other aminoglycoside antibiotics to mammalian cells results in the release of GPI-anchored proteins","volume":"409","author":"Kung","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2021.101073_bib47","doi-asserted-by":"crossref","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","article-title":"A\u00a0naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation","volume":"286","author":"Westergard","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib48","first-page":"15","article-title":"Proteolytic processing of the prion protein in health and disease","volume":"1","author":"Altmeppen","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.jbc.2021.101073_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/pri.22511","article-title":"alpha-Cleavage of cellular prion protein","volume":"6","author":"Liang","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.jbc.2021.101073_bib50","doi-asserted-by":"crossref","first-page":"27718","DOI":"10.1074\/jbc.M111.234393","article-title":"A\u00a0survey of antiprion compounds reveals the prevalence of non-PrP molecular targets","volume":"286","author":"Poncet-Montange","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib51","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1074\/jbc.RA120.014905","article-title":"Multimodal small-molecule screening for human prion protein binders","volume":"295","author":"Reidenbach","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib52","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2021.101073_bib53","doi-asserted-by":"crossref","first-page":"16990","DOI":"10.1073\/pnas.0909006106","article-title":"Natural and synthetic prion structure from X-ray fiber diffraction","volume":"106","author":"Wille","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib55","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1073\/pnas.97.26.14295","article-title":"Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy","volume":"97","author":"Duesberg","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib56","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/JVI.74.7.3135-3140.2000","article-title":"Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures","volume":"74","author":"Mange","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib57","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1128\/jvi.68.11.7534-7536.1994","article-title":"Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection","volume":"68","author":"McKenzie","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib58","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1128\/jvi.71.12.9685-9689.1997","article-title":"Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals","volume":"71","author":"Demaimay","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib59","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.101073_bib61","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/165.4.784","article-title":"Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy","volume":"165","author":"Masullo","year":"1992","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jbc.2021.101073_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Haik","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2021.101073_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: A double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jbc.2021.101073_bib64","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","article-title":"Sense from nonsense: Therapies for premature stop codon diseases","volume":"18","author":"Bidou","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2021.101073_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52611","article-title":"Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides","volume":"9","author":"Wangen","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2021.101073_bib66","first-page":"OL23","article-title":"Translational errors as an early event in prion conversion","volume":"47","author":"Hatin","year":"2001","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.jbc.2021.101073_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000673","article-title":"Continuous quinacrine treatment results in the formation of drug-resistant prions","volume":"5","author":"Ghaemmaghami","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1183218","article-title":"Darwinian evolution of prions in cell culture","volume":"327","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.101073_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003158","article-title":"Acquisition of drug resistance and dependence by prions","volume":"9","author":"Oelschlegel","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib70","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1073\/pnas.0409651102","article-title":"Diagnosis of human prion disease","volume":"102","author":"Safar","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002547","article-title":"PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP","volume":"8","author":"Sajnani","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib72","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A\u00a0systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2021.101073_bib73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","article-title":"The most infectious prion protein particles","volume":"437","author":"Silveira","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101073_bib74","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0960-9822(02)00722-4","article-title":"Transfer of scrapie prion infectivity by cell contact in culture","volume":"12","author":"Kanu","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2021.101073_bib75","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1073\/pnas.0708372104","article-title":"Cell division modulates prion accumulation in cultured cells","volume":"104","author":"Ghaemmaghami","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncb1841","article-title":"Prions hijack tunnelling nanotubes for intercellular spread","volume":"11","author":"Gousset","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2021.101073_bib77","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1073\/pnas.0308413101","article-title":"Cells release prions in association with exosomes","volume":"101","author":"Fevrier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.101073_bib78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in\u00a0vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101073_bib79","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1038\/ncomms5347","article-title":"Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked","volume":"5","author":"Sandberg","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2021.101073_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005623","article-title":"A\u00a0neuronal culture system to detect prion synaptotoxicity","volume":"12","author":"Fang","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jbc.2021.101073_bib81","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1074\/jbc.M109.064949","article-title":"A\u00a0novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein","volume":"285","author":"Massignan","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib82","doi-asserted-by":"crossref","first-page":"26164","DOI":"10.1074\/jbc.M116.745612","article-title":"Identification of anti-prion compounds using a novel cellular assay","volume":"291","author":"Imberdis","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib83","doi-asserted-by":"crossref","first-page":"26719","DOI":"10.1074\/jbc.M110.134619","article-title":"Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells","volume":"285","author":"Solomon","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101073_bib84","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1523\/JNEUROSCI.3406-12.2013","article-title":"A\u00a0mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity","volume":"33","author":"Biasini","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2021.101073_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114594","article-title":"CRISPR-Cas9-based knockout of the prion protein and its effect on the proteome","volume":"9","author":"Mehrabian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.101073_bib86","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1128\/JVI.72.11.9413-9418.1998","article-title":"Mapping the prion protein using recombinant antibodies","volume":"72","author":"Williamson","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101073_bib87","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nbt748","article-title":"Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice","volume":"20","author":"Safar","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2021.101073_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003872","article-title":"The POM monoclonals: A comprehensive set of antibodies to non-overlapping prion protein epitopes","volume":"3","author":"Polymenidou","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.101073_bib89","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/v8050140","article-title":"Factors that improve RT-QuIC detection of prion seeding activity","volume":"8","author":"Orru","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2021.101073_bib90","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1039\/C4CP05563B","article-title":"On the lag phase in amyloid fibril formation","volume":"17","author":"Arosio","year":"2015","journal-title":"Phys. Chem. Chem. Phys."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821008760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821008760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:50:04Z","timestamp":1778637004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821008760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0021925821008760"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101073","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The aminoglycoside G418 hinders de novo prion infection in cultured cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101073"}}